Vicarious Surgical INC 8-K filings

Vicarious Surgical will implement a 1-for-30 reverse stock split to increase its share price and comply with New York Stock Exchange listing rules.

Vicarious Surgical announced a decrease in operating expenses and net loss for the first quarter of 2024, alongside reiterating their full-year cash burn guidance.

Vicarious Surgical announced its fourth quarter and full year 2023 financial results, highlighting progress on its Version 1.0 surgical system and narrowing its 2024 cash burn guidance.

Vicarious Surgical Inc. announces the resignation of its Executive Chairman, David Styka, effective February 29, 2024.

Vicarious Surgical has appointed Randy Clark as President, effective January 29, 2024, to oversee key business functions as the company prepares for the finalization of its V1.0 system.